The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2019

Filed:

Feb. 19, 2016
Applicant:

Omthera Pharmaceuticals Inc., Wilmington, DE (US);

Inventors:

Hironori Kubota, Tokyo, JP;

Etienne Thierry Charles Rogeau, Beinheim, FR;

Tohru Amemiya, Shizuoka Pref., JP;

Julien Georges Meissonnier, Beinheim, FR;

Anders Gillis Holmén, Molndal, SE;

Andreas Rådevik, Molndal, SE;

Hans Carlsson, Molndal, SE;

Bengt Staffan Schantz, Molndal, SE;

Assignee:

Omthera Pharmaceuticals Inc., Wilmington, DE (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 31/202 (2006.01); A61P 1/16 (2006.01); A61P 3/06 (2006.01); A61P 11/00 (2006.01); A61K 9/50 (2006.01); A61K 31/135 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4891 (2013.01); A61K 9/4808 (2013.01); A61K 9/4825 (2013.01); A61K 9/4833 (2013.01); A61K 31/202 (2013.01); A61P 1/16 (2018.01); A61P 3/06 (2018.01); A61P 11/00 (2018.01); A61K 9/5026 (2013.01); A61K 9/5047 (2013.01); A61K 9/5057 (2013.01); A61K 31/135 (2013.01); A61K 2300/00 (2013.01);
Abstract

Capsular dosage forms containing polyunsaturated fatty acid (PUFA) compositions are provided herein. In certain embodiments, unit dosage forms comprising a plurality of millicapsules containing a PUFA composition therein are provided as well as their methods of use and manufacture. In certain embodiments, capsular dosage forms are provided herein that include a unit dosage form comprising a plurality of millicapsules containing a polyunsaturated free fatty acid substantially in free acid form. In some embodiments, the PUFA composition is Epanova®.


Find Patent Forward Citations

Loading…